Hepatitis C in northern Norway;Hepatitt C i Nord-Norge - Et åtteårsmateriale

Tidsskrift for den Norske Laegeforening

Volumn 122, Issue 20, 2002, Pages 1974-1976

  Kristiansen, Magnhild Gangsøy ^a   Gutteberg, Tore ^a   Berg, Leif Kyrre ^a   Sjursen, Haakon ^a   Mortensen, Liisa ^a   Florholmen, Jon ^a  

^a Medisinsk Avdeling   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL FEATURE; DISEASE COURSE; DISEASE TRANSMISSION; DRUG ABUSE; FEMALE; HEALTH PROGRAM; HEPATITIS C; HUMAN; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; NORWAY; PRIMARY MEDICAL CARE; SCREENING;

ADOLESCENT; ADULT; BLOOD TRANSFUSION; BLOOD-BORNE PATHOGENS; CHILD; FEMALE; FOLLOW-UP STUDIES; HEPATITIS C; HUMANS; IMMUNOBLOTTING; MALE; MASS SCREENING; MIDDLE AGED; NORWAY; RISK FACTORS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 0037200710     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Hoofnagle JH, Tralka TS. The National Institutes of Health Consensus Development Conference. Management of hepatitis C. Hepatology 1997; 26 (suppl 1): 1.
2. Boyer N, Marcellin P. Pathogenesis, diagnosis and management of hepatitis C. J Hepatol 2000; 32 (suppl 1) 98-112.
3. Marcellin P. Hepatitis C: the clinical spectrum of the disease. J Hepatol 1999; 31 (suppl 1): 9-16.
4. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244: 359-62.
5. Palitzsch KD, Hottenträger B, Schlottmann K, Frick E, Holstege A, Schölmerich J et al. Prevalence of antibodies against hepatitis C virus in the adult German population. Eur J Gastroenterol Hepatol 1999; 11: 1215-20.
6. Dhillon AP, Husheiko GM. Pathology of hepatitis C virus infection. Hepatology 1995; 26: 297-309.
7. Verbaan H. Hepatitis C virus infection: Epidemiology and routes of transmission. Review Series Hepatitis 2001; 1: 2-6.
8. Datz C, Cramp M, Haas T, Dietze O, Nitschko H, Froesner G et al. The natural course of hepatitis C virus infection 18 years after an epidemic outbreak of non-A, non-B hepatitis in a plasmapheresis centre. Gut 1999; 44: 563-7.
9. Ackerman Z, Ackerman E, Paltiel O. Intrafamilial transmission of hepatitis C virus: A systematic review. J Viral Hepat 2000; 7: 93-103.
10. Thornburn D, Dundas D, McCruden EAB, Cameron SO, Goldberg DJ, Symington IS et al. A study of hepatitis C prevalence in healthcare workers in the West of Scotland. Gut 2001; 48: 116-20.
11. Hoofnagle JH, Mullen KD, Jones DB, Rustgi V, Bisceglie AD, Peters M et al. Treatment of chronic non-A, non-B hepatitis with recombinant human alpha interferon. N Engl J Med 1986; 315: 1575-8.
12. Kristiansen MG, Husebekk A, Mollnes TE, Gutteberg T, Halvorsen D, Mortensen L et al. Prevalence of hepatitis C virus infection in blood donors in northern part of Norway. Abstrakt. Scand J Gastroentero 11999; 34: (suppl): A 28.
13. El-Serag HB, Kunik M, Richardson PA, Rabeneck L. Psychiatric and drug use disorders among veterans infected with hepatitis C virus. Abstrakt. Gastroenterol 2001; 120 (suppl 1): 2092.
14. Shehab T, Sonnad S, Gebremariam A, Lok ASF. Identification and treatment of hepatitis C patients in primary care clinics. Abstrakt. Gastroenterol 2000; 244: A 47.
15. Hepatitis C global prevalence. WHO Weekly Epidemiol Rec 1997; 72: 431-48.
16. Thomas DL, Astemborski J, Rai RM, Anania FA, Schaeffer M, Galai N et al. The natural history of hepatitis C virus infection. JAMA 2000; 284: 450-6.
17. Consensus Panel. EASL International consensus conference on hepatitis C. Consensus statement. J Hepatol 1999; 30: 956-61.
18. Gordon F. Cost-effectiveness of screening patients for hepatitis C. Am J Med 1999; 107: 36-40.